Invion Limited
ASX:IVX.AX
Overview | Financials
Company Name | Invion Limited |
Symbol | IVX.AX |
Currency | AUD |
Price | 0.002 |
Market Cap | 13,533,180 |
Dividend Yield | 0% |
52-week-range | 0.002 - 0.008 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Thian Chew |
Website | https://www.inviongroup.com |
An error occurred while fetching data.
About Invion Limited
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a photosensitizer agent to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD